Dennis Hom
2023
In 2023, Dennis Hom earned a total compensation of $745.5K as Former Chief Financial Officer at Sagimet Biosciences, a 60% increase compared to previous year.
Compensation breakdown
| Salary | $226,069 |
|---|---|
| Other | $519,438 |
| Total | $745,507 |
Hom received $519.4K in other compensation, accounting for 70% of the total pay in 2023.
Hom also received $226.1K in salary.
Rankings
In 2023, Dennis Hom's compensation ranked 1,439th out of 2,647 executives tracked by ExecPay. In other words, Hom earned more than 45.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,439 out of 2,647 | 46th |
Division Manufacturing | 846 out of 1,447 | 42nd |
Major group Chemicals And Allied Products | 545 out of 817 | 33rd |
Industry group Drugs | 529 out of 783 | 32nd |
Industry Pharmaceutical Preparations | 366 out of 555 | 34th |
Source: SEC filing on April 18, 2024.
Hom's colleagues
We found three more compensation records of executives who worked with Dennis Hom at Sagimet Biosciences in 2023.